Bio-Rad Laboratories Class A
200 hedge funds and large institutions have $2.11B invested in Bio-Rad Laboratories Class A in 2014 Q3 according to their latest regulatory filings, with 20 funds opening new positions, 79 increasing their positions, 72 reducing their positions, and 22 closing their positions.
10% more repeat investments, than reductions
Existing positions increased: 79 | Existing positions reduced: 72
0.71% more ownership
Funds ownership: 77.69% → 78.4% (+0.71%)
4% less capital invested
Capital invested by funds: $2.21B → $2.11B (-$91.7M)
9% less first-time investments, than exits
New positions opened: 20 | Existing positions closed: 22
2% less funds holding
Funds holding: 204 → 200 (-4)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EIP
Epoch Investment Partners
New York
|
+$22.3M |
| 2 |
AI
Ariel Investments
Chicago,
Illinois
|
+$9.93M |
| 3 |
LCS
Levin Capital Strategies
New York
|
+$9.37M |
| 4 |
TCM
Tamarack Capital Management
Carlsbad,
California
|
+$7.94M |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
+$6.9M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Norges Bank
Oslo,
Norway
|
-$18.3M |
| 2 |
RA
Royce & Associates
New York
|
-$17.7M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$14.8M |
| 4 |
CIP
Champlain Investment Partners
Burlington,
Vermont
|
-$14.6M |
| 5 |
Wells Fargo
San Francisco,
California
|
-$10.7M |
BIO Hedge Fund Activity: Q3 2014 in Review
200 of the 3,455 institutional investors tracked by Wall St. Rank reported a position in Bio-Rad Laboratories Class A (BIO) for Q3 2014, worth a combined $2.11B — down 4.2% from $2.21B a quarter earlier.
Sellers outnumbered buyers: 22 funds closed out of BIO and 20 opened new positions — a net loss of 2 holders — while 72 trimmed existing stakes and 79 added.
The largest buyer was Epoch Investment Partners, opening a new position worth an estimated $22.3M. The largest seller was Norges Bank, cutting an estimated $18.3M.
- 200 institutional investors held Bio-Rad Laboratories Class A (BIO) as of Q3 2014, down from 204 in Q2 2014.
- Funds reported $2.11B of Bio-Rad Laboratories Class A stock for Q3 2014, down 4.2% quarter-over-quarter.
- 20 funds opened new Bio-Rad Laboratories Class A positions in Q3 2014 and 22 closed out, a net change of -2 holders.
- The largest Bio-Rad Laboratories Class A buyer in Q3 2014 was Epoch Investment Partners, an estimated $22.3M added.
- The largest Bio-Rad Laboratories Class A seller in Q3 2014 was Norges Bank, an estimated $18.3M sold.
Based on aggregated 13F filings for Q3 2014.